Authors:
LACY SA
HITCHCOCK MJM
LEE WA
TELLIER P
CUNDY KC
Citation: Sa. Lacy et al., EFFECT OF ORAL PROBENECID COADMINISTRATION ON THE CHRONIC TOXICITY AND PHARMACOKINETICS OF INTRAVENOUS CIDOFOVIR IN CYNOMOLGUS MONKEYS, TOXICOLOGICAL SCIENCES, 44(2), 1998, pp. 97-106
Authors:
HITCHCOCK MJM
JAFFE HS
MARTIN JC
STAGG RJ
Citation: Mjm. Hitchcock et al., CIDOFOVIR, A NEW AGENT WITH POTENT ANTI-HERPESVIRUS ACTIVITY, Antiviral chemistry & chemotherapy, 7(3), 1996, pp. 115-127
Authors:
CUNDY KC
LYNCH G
SHAW JP
HITCHCOCK MJM
LEE WA
Citation: Kc. Cundy et al., DISTRIBUTION AND METABOLISM OF INTRAVITREAL CIDOFOVIR AND CYCLIC HPMPC IN RABBITS, Current eye research, 15(5), 1996, pp. 569-576
Citation: Kc. Cundy et al., PHARMACOKINETICS OF CIDOFOVIR IN MONKEYS - EVIDENCE FOR A PROLONGED ELIMINATION PHASE REPRESENTING PHOSPHORYLATED DRUG, Drug metabolism and disposition, 24(7), 1996, pp. 738-744
Authors:
CHERRINGTON JM
MINER R
HITCHCOCK MJM
LALEZARI JP
DREW WL
Citation: Jm. Cherrington et al., SUSCEPTIBILITY OF HUMAN CYTOMEGALOVIRUS TO CIDOFOVIR IS UNCHANGED AFTER LIMITED IN-VIVO EXPOSURE TO VARIOUS CLINICAL REGIMENS OF DRUG, The Journal of infectious diseases, 173(4), 1996, pp. 987-992
Authors:
CUNDY KC
PETTY BG
FLAHERTY J
FISHER PE
POLIS MA
WACHSMAN M
LIETMAN PS
LALEZARI JP
HITCHCOCK MJM
JAFFE HS
Citation: Kc. Cundy et al., CLINICAL PHARMACOKINETICS OF CIDOFOVIR IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, Antimicrobial agents and chemotherapy, 39(6), 1995, pp. 1247-1252
Authors:
BISCHOFBERGER N
HITCHCOCK MJM
CHEN MS
BARKHIMER DB
CUNDY KC
KENT KM
LACY SA
LEE WA
LI ZH
MENDEL DB
SMEE DF
SMITH JL
Citation: N. Bischofberger et al., -OXO-1,4,2-DIOXAPHOSPHORINAN-5-YL)METHYL]CYTOSINE, AN INTRACELLULAR PRODRUG FOR S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)CYTOSINE WITH IMPROVED THERAPEUTIC INDEX IN-VIVO, Antimicrobial agents and chemotherapy, 38(10), 1994, pp. 2387-2391
Authors:
TORTOLANI DR
RUSSELL JW
WHITEROCK VJ
HITCHCOCK MJM
GHAZZOULI I
MARTIN JC
MANSURI MM
STARRETT JE
Citation: Dr. Tortolani et al., PRODRUGS OF 2',3'-DIDEHYDRO-3'-DEOXYTHYMIDINE (D4T) - SYNTHESIS, ANTIVIRAL ACTIVITY, AND RAPID PHARMACOKINETIC EVALUATION, Journal of pharmaceutical sciences, 83(3), 1994, pp. 339-343
Authors:
STARRETT JE
TORTOLANI DR
RUSSELL J
HITCHCOCK MJM
WHITEROCK V
MARTIN JC
MANSURI MM
Citation: Je. Starrett et al., SYNTHESIS, ORAL BIOAVAILABILITY DETERMINATION, AND IN-VITRO EVALUATION OF PRODRUGS OF THE ANTIVIRAL AGENT 9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE (PMEA), Journal of medicinal chemistry, 37(12), 1994, pp. 1857-1864
Authors:
CRETTON EM
ZHOU Z
KIDD LB
MCCLURE HM
KAUL S
HITCHCOCK MJM
SOMMADOSSI JP
Citation: Em. Cretton et al., IN-VITRO AND IN-VIVO DISPOSITION AND METABOLISM OF 3'-DEOXY-2',3'-DIDEHYDROTHYMIDINE, Antimicrobial agents and chemotherapy, 37(9), 1993, pp. 1816-1825
Authors:
YU KL
BRONSON JJ
YANG HY
PATICK A
ALAM M
BRANKOVAN V
DATEMA R
HITCHCOCK MJM
MARTIN JC
Citation: Kl. Yu et al., SYNTHESIS AND ANTIVIRAL ACTIVITY OF 2'-SUBSTITUTED 9-[2-(PHOSPHONOMETHOXY)ETHYL]GUANINE ANALOGS, Journal of medicinal chemistry, 36(19), 1993, pp. 2726-2738
Authors:
HO HT
WOODS KL
BRONSON JJ
DEBOECK H
MARTIN JC
HITCHCOCK MJM
Citation: Ht. Ho et al., INTRACELLULAR METABOLISM OF THE ANTIHERPES AGENT -1-[3-HYDROXY-2-(PHOSPHONYLMETHOXY)PROPYL]CYTOSINE, Molecular pharmacology, 41(1), 1992, pp. 197-202